Understanding Ovarian Cysts
Ovarian cysts most commonly occur as a result of a failure to ovulate. Cysts often arise as a side-effect in those who suffer from Polycistic Ovarian Syndrome, or PCOS.
Women with PCOS fail to ovulate and have very few periods in a year, which disrupts the usual hormone regulation process. Ovarian cysts can lead from dull aches to more serious conditions such as infertility. Cysts that don't spontaneously resolve after 3 months require further investigation, as they could be cancerous.
Evaluate your symptoms with the online Progesterone Deficiency Symptoms assessment quiz.
This free booklet explains the role of progesterone in the female body and how many other aspects of a woman’s quality of life can be affected by inadequate progesterone production. These are summarized in the Progesterone booklet displayed opposite.
Downloading the booklet(s) is FREE.
- Natural Progesterone Cream - an Introduction
- Natural Progesterone - A History
- Natural Progesterone Deficiency and Estrogen Dominance
- Estrogen Dominance and the Menopausal and Peri-menopausal years
- Natural Progesterone - Treatment Options
- Period Pain
- Irregular and Heavy Menstrual Bleeding
- Breast Disorders
- Depression and anxiety attacks
- Premenstrual Syndrome (PMS)
- Hormonal-induced Headaches and Migraines
- Anovulation
Products
ProFeme® 3.2% and 10% Progesterone Cream is specifically targeted for use in women with declined or lowered progesterone levels. Low progesterone in women is associated with mood changes, premenstrual symptoms (PMS), altered menstrual flow and irregularities, menopausal symptoms including hot flashes, night sweats, vaginal dryness and skin itching, endometriosis, ovarian cysts, uterine fibroids, pregnancy complications, infertility and posterior blepharitis (eye irritation). ProFeme® Progesterone Cream for women is the world's only clinically trialled and tested pharmaceutical grade progesterone cream. Using natural or bio identical progesterone ProFeme® Progesterone Cream for women is made in two strengths; 3.2% and 10% and is government listed (AUST L 66355 and 95335) and is now available online.
